|
Cardiovascular Disease/ Myocardial Infarction
Citations 281-290 of 1004 total displayed.
|
Past content
(since Feb 1998):
|
- Editorials
Homocysteine-Lowering B Vitamin Therapy in Cardiovascular Prevention—Wrong Again?
- Eva Lonn
JAMA 2008; 299: 2086-2087.
[Extract]
[Full text]
[PDF]
- JAMA Patient Page
Smoking and the Heart
- Sharon Parmet; Cassio Lynm; Richard M. Glass
JAMA 2008; 299: 2112.
[Extract]
[Full text]
[PDF]
[ Spanish PDF ]
- Letters
Misinterpretation of Electrocardiograms and Cardiac Catheterization Laboratory Activations—Reply
- David M. Larson; Scott W. Sharkey; Timothy D. Henry
JAMA 2008; 299: 1897-a-1898-a.
[Extract]
[Full text]
[PDF]
- Letters
Misinterpretation of Electrocardiograms and Cardiac Catheterization Laboratory Activations
- Andrew T. Yan; Raymond T. Yan; Shaun G. Goodman
JAMA 2008; 299: 1897.
[Extract]
[Full text]
[PDF]
- Letters
Misinterpretation of Electrocardiograms and Cardiac Catheterization Laboratory Activations—Reply
- Frederick A. Masoudi
JAMA 2008; 299: 1898.
[Extract]
[Full text]
[PDF]
- Original Contributions
Comparison of an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients With Coronary Artery Disease: A Randomized Trial
- Gregg W. Stone; Mark Midei; William Newman; Mark Sanz; James B. Hermiller; Jerome Williams; Naim Farhat; Kenneth W. Mahaffey; Donald E. Cutlip; Peter J. Fitzgerald; Poornima Sood; Xiaolu Su; Alexandra J. Lansky; for the SPIRIT III Investigators
JAMA 2008; 299: 1903-1913.
[Abstract]
[Full text]
[PDF]
- Editorials
Next-Generation Drug-Eluting Stents: A Spirited Step Forward or More of the Same
- Manesh R. Patel; David R. Holmes Jr
JAMA 2008; 299: 1952-1953.
[Extract]
[Full text]
[PDF]
- Original Contributions
Efficacy and Safety of Pyridoxal 5'-Phosphate (MC-1) in High-Risk Patients Undergoing Coronary Artery Bypass Graft Surgery: The MEND-CABG II Randomized Clinical Trial
- MEND-CABG II Investigators*
JAMA 2008; 299: 1777-1787.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Comparison of Angioplasty With Infusion of Tirofiban or Abciximab and With Implantation of Sirolimus-Eluting or Uncoated Stents for Acute Myocardial Infarction: The MULTISTRATEGY Randomized Trial
- Marco Valgimigli; Gianluca Campo; Gianfranco Percoco; Leonardo Bolognese; Corrado Vassanelli; Salvatore Colangelo; Nicoletta de Cesare; Alfredo E. Rodriguez; Maurizio Ferrario; Raul Moreno; Tommaso Piva; Imad Sheiban; Giampaolo Pasquetto; Francesco Prati; Marco S. Nazzaro; Giovanni Parrinello; Roberto Ferrari; for the Multicentre Evaluation of Single High-Dose Bolus Tirofiban vs Abciximab With Sirolimus-Eluting Stent or Bare Metal Stent in Acute Myocardial Infarction Study (MULTISTRATEGY) Investigators
JAMA 2008; 299: 1788-1799.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes: The SANDS Randomized Trial
- Barbara V. Howard; Mary J. Roman; Richard B. Devereux; Jerome L. Fleg; James M. Galloway; Jeffrey A. Henderson; Wm. James Howard; Elisa T. Lee; Mihriye Mete; Bryce Poolaw; Robert E. Ratner; Marie Russell; Angela Silverman; Mario Stylianou; Jason G. Umans; Wenyu Wang; Matthew R. Weir; Neil J. Weissman; Charlton Wilson; Fawn Yeh; Jianhui Zhu
JAMA 2008; 299: 1678-1689.
[Abstract]
[Full text]
[PDF]
[ JAMA Report Video ] [ Author in the Room™ Teleconference ]
|
|
